We are live on ! Find out more
RJFSA

Raymond James Financial Services Advisors Portfolio holdings

AUM $75.1B
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
-12.99%
1 Year Est. Return
+31.89%
3 Year Est. Return
+38.17%
5 Year Est. Return
+106.56%
10 Year Est. Return
+236.84%
AUM
$46B
AUM Growth
-$7.02B
Cap. Flow
+$701M
Cap. Flow %
1.52%
Top 10 Hldgs %
15.31%
Holding
3,506
New
172
Increased
1,455
Reduced
1,478
Closed
252

Sector Composition

Rank Sector Weight
1 Technology 10.94%
2 Healthcare 6.67%
3 Financials 6.62%
4 Consumer Discretionary 4.8%
5 Industrials 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DARE icon
3101
Dare Bioscience
DARE
$21.6M
$37K ﹤0.01%
2,500
NGL icon
3102
NGL Energy Partners
NGL
$2.13B
$37K ﹤0.01%
24,636
+300
+1% +$589
ROI
3103
DELISTED
RiskOn International, Inc. Common Stock
ROI
$37K ﹤0.01%
470
-13
-3% -$808
APRN
3104
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$37K ﹤0.01%
+840
New +$34.2K
BBIG
3105
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$37K ﹤0.01%
1,325
-365
-22% -$12.2K
GORO icon
3106
Goldgroup Mining Inc.
GORO
$184M
$35K ﹤0.01%
21,292
NVTA
3107
DELISTED
Invitae Corporation
NVTA
$35K ﹤0.01%
14,421
+1,811
+14% +$8.01K
ACHR icon
3108
Archer Aviation
ACHR
$5.23B
$34K ﹤0.01%
11,132
+775
+7% +$3.12K
FRSX
3109
Foresight Autonomous Holdings
FRSX
$4.2M
$34K ﹤0.01%
438
+12
+3% +$1.18K
GWH.WS
3110
DELISTED
ESS Tech Inc Warrant
GWH.WS
$34K ﹤0.01%
100,000
UAMY icon
3111
United States Antimony
UAMY
$975M
$34K ﹤0.01%
+85,366
New +$37.1K
BGMS
3112
Bio Green Med Solution Inc
BGMS
$4.97M
$33K ﹤0.01%
9
+6
+200% +$36.3K
EXK
3113
Endeavour Silver
EXK
$3.14B
$33K ﹤0.01%
10,450
HRTX icon
3114
Heron Therapeutics
HRTX
$61.5M
$33K ﹤0.01%
11,786
-25
-0.2% -$100
WKHS icon
3115
Workhorse Group
WKHS
$34.1M
$33K ﹤0.01%
4
-1
-20% -$9.44K
BODI icon
3116
The Beachbody Company
BODI
$45.8M
$33K ﹤0.01%
551
+30
+6% +$2.43K
BCLI
3117
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$32K ﹤0.01%
783
-19
-2% -$856
SPRU icon
3118
Spruce Power Holding Corp
SPRU
$38.4M
$32K ﹤0.01%
3,505
+1,386
+65% +$16K
STAB
3119
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$32K ﹤0.01%
112,250
AGEN
3120
Agenus
AGEN
$307M
$30K ﹤0.01%
790
OCGN icon
3121
Ocugen
OCGN
$465M
$30K ﹤0.01%
13,302
-1,045
-7% -$2.5K
OESX icon
3122
Orion Energy Systems
OESX
$80.8M
$30K ﹤0.01%
1,480
JMIA
3123
CALL
Jumia Technologies
JMIA
$720M
$29K ﹤0.01%
39,200
+19,200
+96% +$140K
MSFT icon
3124
CALL
Microsoft
MSFT
$3.74T
$29K ﹤0.01%
11,600
GRTX
3125
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$29K ﹤0.01%
22,311

Similar funds

Raymond James Financial Services Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James Financial Services Advisors held 3,506 positions worth $46B, down 13% from $53B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James Financial Services Advisors's Q2 2022 filing shows 172 new, 1,455 increased, 1,478 reduced and 252 closed positions. Its largest new stake was FT Vest US Equity Buffer ETF May: 1,069,907 shares worth $36.8M. The largest sale was iShares Core US Aggregate Bond ETF, an estimated $55.1M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James Financial Services Advisors's largest Q2 2022 buy was FT Vest US Equity Buffer ETF May: 1,069,907 shares worth $36.8M.
  • Raymond James Financial Services Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2022, an estimated $100M increase.
  • Raymond James Financial Services Advisors's biggest Q2 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $55.1M.
  • Raymond James Financial Services Advisors fully exited iShares MSCI Taiwan ETF in Q2 2022, selling an estimated $8.52M.
  • Raymond James Financial Services Advisors's ten largest holdings make up 15% of its $46B portfolio in Q2 2022.
  • Raymond James Financial Services Advisors opened 172 new positions and closed 252 in Q2 2022.
  • Raymond James Financial Services Advisors's portfolio value fell 13% quarter-over-quarter to $46B.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.